Abstract
Purpose: Endometriosis is an inflammatory disease characterized by the presence of endometrial tissue outside the uterine cavity. Animal models that reflect the characteristics of human disease have been critical for research in this field. We sought to develop and validate a novel rat model for endometriosis, incorporating vascular endothelial growth factor (VEGF) to enhance disease formation and explore disease-related characteristics.Materials and Methods: Forty adult female non-mated Wistar albino rats were divided into four groups: control, Vernon-Wilson method, peritoneal endometrial tissue injection, and peritoneal endometrial tissue injection with VEGF pre-treatment. All rats underwent oophorectomy to stabilize estrogen levels, followed by oral administration of 17β-estradiol for 21 days. Histopathological and immunohistochemical evaluations were performed to assessendometriosis severity, stromal development, CD10 positivity, estrogen receptor (ER) staining, VEGF staining, and inflammatory activity.Results: All three models generated significant differences compared to controls. The injection + VEGFgroup exhibited extensive endometriosis development, with higher epithelial density, stromal presence, andVEGF staining intensity compared to other groups, and similar overall endometriosis score to the Vernon-Wilson model. ER positivity was most pronounced in the Vernon-Wilson group, while stromal density and angiogenesis were higher in VEGF recipients.Conclusion: This study introduces a VEGF-enhanced rat model as an efficient and reproducible tool for studying endometriosis. This model emulates pathological features associated with endometriosis, including angiogenesis, immune response, and inflammation, but does not appear to generate ER positivity at the level of the Vernon-Wilson model. Despite this limitation, we believe this simple and efficient model can be crucial for researchers studying endometriosis.